ATC code L01
Abemaciclib
Acalabrutinib
Adagrasib
Afatinib
Alectinib
Alemtuzumab
Alpelisib
American Society of Health-System Pharmacists
Amivantamab
Anaplastic lymphoma kinase
Anatomical Therapeutic Chemical Classification System
Antibody
Antifolate
Antimetabolite
Antineoplastic
Asciminib
Atezolizumab
Aumolertinib
Avapritinib
Avelumab
Axatilimab
Axitinib
BRAF (gene)
Baricitinib
Belantamab mafodotin
Bermekimab
Bevacizumab
Binimetinib
Blinatumomab
Bosutinib
Brentuximab vedotin
Brigatinib
Bruton's tyrosine kinase
CAS Registry Number
CD135
CD20
CD30
CD33
CD3 (immunology)
CD52
CDK inhibitor
Cabozantinib
Cancer immunotherapy
Capmatinib
Catumaxomab
Cediranib
Cemiplimab
Centers for Medicare & Medicaid Services
Ceritinib
Cetuximab
ChemSpider
Chemical formula
Cobimetinib
Colorectal cancer
Copanlisib
Cosibelimab
Crizotinib
Dabrafenib
Dacomitinib
DailyMed
Dalpiciclib
Daratumumab
Dasatinib
Denileukin diftitox
Doi (identifier)
Dostarlimab
Durvalumab
Duvelisib
EML4
Edrecolomab
Elotuzumab
Elranatamab
Encorafenib
Enfortumab vedotin
Entrectinib
Epcoritamab
Epidermal growth factor receptor
ErbB
Erdafitinib
Erlotinib
Everolimus
Exotoxin
Fedratinib
Fibroblast growth factor receptor
Filgotinib
Fluorouracil
Folinic acid
Food and Drug Administration
Fruquintinib
Fusion protein
Futibatinib
Gefitinib
Gemtuzumab ozogamicin
Gilteritinib
Glasdegib
Glofitamab
Hedgehog signaling pathway
Ibritumomab tiuxetan
Ibrutinib
Icotinib
Idelalisib
Imatinib
Immunosuppression
Immunosuppressive drug
Inavolisib
Infigratinib
Inotuzumab ozogamicin
Interleukin 2
Intravenous therapy
Ipilimumab
Irinotecan
Isatuximab
Janus kinase
KRAS
Lapatinib
Medicare (United States)
Molar mass
PMC (identifier)
PMID (identifier)